Abstract 1935P
Background
The tertiary lymphoid structure (TLS) is an important part of the tumor microenvironment. It generates circulating immune cells and inhibits tumor growth and progression, which is closely related to the efficacy of immunotherapy.
Methods
This study collected the transcriptome information and clinical data of 10327 tumor samples and 730 normal samples of 33 cancer types from the TCGA database. Based on previous literature, three sets of TLS-related gene sets were selected and merged into the total TLS gene set. The TLS enrichment scores were calculated by the GSVA algorithm. Further, utilize TIMER 2.0 and CIBERSORTNE algorithms to analyze the distribution of tumor-infiltrating immune cells. Based on the enrichment score of TLS, sarcoma patients were divided into three TLS subtypes via the "hclust" R package. TLS-related prognostic core genes were screened via Lasso Cox and multivariate Cox regression and further used to establish the TLS-related prognostic signature. The public immunotherapy cohorts and our center immunotherapy patients were used to validate the efficacy of immunotherapy.
Results
The TLS gene set enrichment score established in this study is significantly positively correlated with immune cell infiltration such as T cells, B cells, and DC cells, which can reflect the TLS status in tumor tissue. Kaplan Meier survival analysis showed that patients with high TLS had better overall survival and progression-free survival compared to patients with low TLS. Through Lasso Cox and multivariate Cox regression, two TLS-related prognostic core genes (TNFRSF14 and DUSP9) were ultimately screened, and a TLS-related prognostic signature was established. Immunohistochemistry showed that the expression of TNFRSF14 was increased and the expression of DUSP9 was reduced in patients with soft tissue sarcoma who achieved optimal immunotherapy.
Conclusions
The TLS-Total gene set, TLS-related prognostic signature, TNFRSF14, and DUSP9 selected in this study can predict the prognosis of patients with soft tissue sarcoma. TNFRSF14 and DUSP9 are associated with immune cell infiltration, which can indicate the efficacy of immunotherapy and may become new predictive markers of immunotherapy efficacy.
Clinical trial identification
No
Editorial acknowledgement
No
Legal entity responsible for the study
The authors.
Funding
Natural Science Basic Research Program of Shaanxi (No. 2021JZ-35).
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1982P - Transcriptomic analysis and tumor microenvironment (TME) classification reveals unique immune biology in HIV patients with Kaposi sarcoma (KS)
Presenter: Jihua Yang
Session: Poster session 15
1983P - Palliative spatially fractionated stereotactic radiation therapy (Lattice) for large sarcoma
Presenter: Gabriela Studer
Session: Poster session 15
1984P - Sex differences in anticancer treatment delivery and toxicity in patients with sarcoma in a reference center
Presenter: Ilaria Tortorelli
Session: Poster session 15
1985P - Expert sarcoma care is the need of the hour: Diagnostic and management challenges at a tertiary-care centre in India
Presenter: Ghazal Tansir
Session: Poster session 15
1986P - Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: An analysis from the OnCovid registry
Presenter: Alessandro Mazzocca
Session: Poster session 15
1987TiP - Pembrolizumab in combination with eftilagimod alpha and radiotherapy in neoadjuvant treatment of patients with soft tissue sarcomas: EFTISARC-NEO trial
Presenter: Katarzyna Kozak
Session: Poster session 15
2213P - Impact of the diagnosis-to-treatment interval on the survival of patients with papillary thyroid cancer
Presenter: Tingting Wei
Session: Poster session 15
2214P - Identification of prognosis-associated genes in locally advanced well-differentiated thyroid cancer using TCGA cohort analysis
Presenter: Ah Ra Jung
Session: Poster session 15
2216P - Clinicopathologic and genetic characteristics of patients of different ages with diffuse sclerosing variant papillary thyroid carcinoma
Presenter: Soo Young Kim
Session: Poster session 15
2220P - MOLTHY project (TTCC-2020-02): A Spanish observational study for MOLecular characterization of THYroid carcinoma
Presenter: Neus Baste Rotllan
Session: Poster session 15